Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.25
Bid: 3.20
Ask: 3.30
Change: 0.00 (0.00%)
Spread: 0.10 (3.125%)
Open: 3.25
High: 3.25
Low: 3.25
Prev. Close: 3.25
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CORRECT: AIM IN BRIEF: Herstal Emerges As Favourite To Acquire Manroy

Thu, 28th Nov 2013 12:27

(Correcting headline to refer to Herstal.)

LONDON (Alliance News) - The following AIM-listed companies are making headlines on Alliance News Professional at the market open Thursday:
--------
Mar City To Buy Eight Plots Of Land For About GBP30.8M; Launches GBP25.8M Placing
----------
NewRiver Retail To Buy 202 Pubs From Marston's For GBP90M; To Convert All Pubs To Other Uses; Buys Two Retail Centres For GBP34.3M; H1 Pretax Profit GBP5.2M Vs GBP479,000; Keeps Interim Dividend At 6.0P
----------
Idox Wins USD1.5M Contract With Unamed Canadian Oil & Gas Co.
----------
Plethora Solutions Says CEO Ronald Openshaw To Step Down; Says Non-Exec Director Mike Collis To Act As CFO; Says Intends To Further Strengthen Management Team
----------
Digital Barriers H1 Pretax Loss GBP7.2M Vs GBP7.1M Loss; Revenue GBP9M Vs GBP8.1M; Appoints New Finance Director
----------
Triple Plate Junction H1 Pretax Loss GBP234K Vs GBP320K; Spent GBP52,000 During The Period On Possible Transactions
----------
Brightside Appoints Paul Williams As New CEO From Early 2014
----------
Manroy Says Has Ended Takeover Talks With U.S. Ordnance But Still Talking With Herstal And Beretta; Says In "Active Discussions" With Herstal; Says Beretta Talks Not Active But Not Terminated
----------
Hummingbird Says Results Confirm Confidence On Tuzon Deposit; To Commence Additional Drilling At Site
----------
M&C Saatchi Agrees To Sell 75.1% Of Walker Media To Publicis Groupe For GBP36M In Cash; Will Retain 24.9% Of Walker Media And Have Right To Appoint Directors
----------
Leni Gas & Oil Says Plans To Drill First New Wells At Goudron Progress; Working With Authorities To Get Final Approvals
----------
Sigma Capital Agrees GBP700M Joint Venture With Gatehouse Bank For UK Privately Rented Residential Properties; JV To Build Initial 2,000 New Rental Homes In 22 Sites In North West Of England; JV Provides For Development Of 4,600 Additional New Rented Homes
----------
Publishing Technology: FY Results To Be Below Expectations Due To Delayed Completion Of Projects; Outlook For 2014 Remains A Steady Improvement
----------
Character Group FY Pretax Profit GBP0.72M Vs GBP7.1M; FY Sales GBP67.2M Vs GBP74.95M; Keeps Final Dividend At 3.30P; Says Saw A Turnaround In H2; Expects Substantially Better Results In 2014
----------
Ceramic Fuel Cells Sells 1,000 BlueGEN Units To Baltic Distributor For Over EUR20M
----------
Legendary Investments Says Virtualstock Limited Has Successfully Implemented Its System With Tesco
----------
Impax Asset Management FY Pretax profit GBP3.4M Vs GBP4.7M Loss; FY Revenue GBP18.5M Vs GBP18.6M
----------
Peninsular Gold FY Pretax Profit GBP2.3M Vs GBP3.0M; Rev From Unhedged Gold Sales GBP22.8M Vs GBP18.7M; Produced 5,836 Ounces Of Gold For Quarter July To Sept 2013
----------
Inland Home Signs Agreement With Defence Infrastructure Organisation For Wilton Park In Beaconsfield
----------
Pilat Media Q3 Profit After Tax GBP32,000 Vs GBP20,000 Loss; Revenue GBP6.29M Vs GBP5.31M; Says Strong Q4 To Results In Strong FY Revenue, Profit Growth
----------
ValiRx Says Has Received More Positive Studies On VAL201
----------
James Latham H1 Pretax Profit GBP4.2M Vs GBP4.1M; Rev GBP82.2M Vs GBP74.9M; Increases Interim Dividend To 3.4P Vs 3.1P
----------
Mercom Oil Sands Reaches Settlement With Nordic Petroleum On Chard Oil Sands Leases; Mercom Oil Sands To Pay Undisclosed Cash Sum, 13M New Shares
----------
Thor Mining Chairman: Challenges Ahead Are Securing Funds, Completing Upgrade To Molyhill Project; On Track To Increase Interest In Spring Hill To 80% By January 31 2014
----------
Mining Investments Resources FY Loss GBP368,000 Vs GBP634,000
----------
All Asia Asset Capital Buys Minority Stake In Myanmar Allure Group
--------
Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
20 Jun 2019 09:54

ValiRx secures 'substantial amendment' to VAL201 clinical trials

(Sharecast News) - Clinical stage biotechnology company ValiRx updated the market on 'VAL201' on Thursday, confirming that, based on clinical results, a "substantial amendment" to the clinical trial protocol had received regulatory approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) and the research ethics committee.

Read more
13 Jun 2019 11:07

ValiRx Subscription Raises GBP300,000 For Drug Trial And Development (ALLISS)

(Alliance News) - ValiRx PLC on Thursday said it raised GBP300,000 via subscription for working capital and to progress the clinical trial of its VALL201 cancer drug.Shares in ValiRx a 31%

Read more
10 Jun 2019 09:50

ValiRx In Discussions With Investor To End Subscription Agreement (ALLISS)

LONDON (Alliance News) - ValiRx PLC on Monday confirmed it is in advanced discussions with European High Growth Opportunities SF to terminate a subscription agreement.Shares in the clinical

Read more
5 Jun 2019 10:54

ValiRx Convertible Bond Talks In Advanced Stage; Plans Open Offer (ALLISS)

LONDON (Alliance News) - ValiRx PLC on Wednesday said it is in advanced discussions with European High Growth Opportunities SF to enter a new convertible bond facility and is planning an open in a

Read more
31 May 2019 12:04

ValiRx Extends Talks With Investor Over New Convertible Bond (ALLISS)

LONDON (Alliance News) - ValiRx PLC on Friday said it has extended the deadline to enter into a new convertible bond with European High Growth Opportunities SF to July 1.The cancer life was

Read more
29 May 2019 10:41

ValiRx Annual Loss Widens On Higher Costs And Fair Value Losses

LONDON (Alliance News) - ValiRx PLC on Wednesday reported a widened annual loss due to higher costs and losses on the fair value of financial assets.For 2018 the life sciences company, on a

Read more
29 May 2019 10:19

ValiRx losses widen as it continues to progress drug development

(Sharecast News) - Life science company ValiRx reported a loss before income tax of £4.83m in its final results on Wednesday, widening from the £3.55m loss it posted a year earlier.

Read more
2 May 2019 15:21

ValiRx Partners With Alpha Blue Ocean And Buys IP Assets Of FIT Bio

LONDON (Alliance News) - ValiRx PLC on Thursday said it has agreed to acquire the IP assets of FIT Bio for EUR5,000 and establish a genetic therapeutic and diagnostic-based joint venture with Blue

Read more
2 May 2019 09:51

ValiRx acquires IP of failed firm FIT Biotech, forms joint venture

(Sharecast News) - Clinical stage biotechnology company ValiRx announced the acquisition of the global granted patents and intellectual property assets of FIT Biotech for a nominal sum on Thursday.

Read more
26 Apr 2019 14:54

ValiRx To Raise GBP1 Million Under Deal With European High Growth (ALLISS)

LONDON (Alliance News) - ValiRx PLC on Friday said it has entered into a GBP1.3 million subscription agreement with European High Growth Opportunities SF.The stock was trading 17% lower on

Read more
26 Mar 2019 10:22

ValiRx Notes ValiSeek Co-Financing Deals For VAL401 Cancer Drug

LONDON (Alliance News) - Biotechnology firm ValiRx PLC on Tuesday said ValiSeek has secured letters of intent from two companies to co-finance the development of cancer drug VAL401.Shares a

Read more
21 Mar 2019 09:53

ValiRx Notes Encouraging Performance Of VAL201 In Cancer Trial

LONDON (Alliance News) - ValiRx PLC on Thursday said an interim inspection of its VAL201 early phase cancer trial shows the drug is performing as predicted.Shares in ValiRx were up 13% at a

Read more
21 Feb 2019 12:46

ValiRx Raises GBP500,000 Through Placing To Advance Clinical Trials (ALLISS)

LONDON (Alliance News) - ValiRx PLC on Thursday raised GBP500,000 through a share placing to expand its clinical trial of VAL201, as well as the VAL301 and VAL101 programmes.ValiRx issued a

Read more
31 Jan 2019 13:37

ValiRx Secures Patent For VAL301 Compound In Russia And China

LONDON (Alliance News) - ValiRx PLC on Thursday said it has been granted a patent allowance for its therapeutic compound VAL301 in both Russia and China.The clinical stage biotechnology has

Read more
31 Jan 2019 10:08

ValiRx allowed patents for VAL401 in Russia and China

(Sharecast News) - Clinical-stage biotechnology company ValiRx announced on Thursday that the patent offices of Russia and China had both granted a patent allowance for its pre-clinical therapeutic compound, VAL301, subject to payment of the relevant fees.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.